Details for New Drug Application (NDA): 212970
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 212970
| Tradename: | SEVELAMER CARBONATE |
| Applicant: | Epic Pharma Llc |
| Ingredient: | sevelamer carbonate |
| Patents: | 0 |
Pharmacology for NDA: 212970
| Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 212970
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 212970 | ANDA | Marp Pharma | 85898-101 | 85898-101-27 | 270 TABLET, FILM COATED in 1 BOTTLE (85898-101-27) |
| SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 212970 | ANDA | INSIGNAMEDEX LLC | 87367-166 | 87367-166-12 | 800 mg in 1 BOTTLE (87367-166-12) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
| Approval Date: | Apr 9, 2020 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
